Glibenclamide/metformin
| Combination of | |
|---|---|
| Sulfonylurea | |
| Metformin | Biguanide |
| Clinical data | |
| Trade names | Glucovance |
| Other names | glyburide/metformin |
| AHFS/Drugs.com | Professional Drug Facts |
| MedlinePlus | a699055 |
| Pregnancy category |
|
| Routes of administration | By mouth |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| CAS Number | |
| KEGG | |
Glibenclamide/metformin, also known as glyburide/metformin and sold under the brand name Glucovance, is a fixed-dose combination anti-diabetic medication used to treat type 2 diabetes. It contains glibenclamide, a sulfonylureas, and metformin, a biguanide.[1]
References[]
- ^ "Glyburide and metformin hydrochloride tablet". DailyMed. 10 June 2020. Retrieved 11 August 2020.
External links[]
- "Glyburide mixture with Metformin hydrochloride". Drug Information Portal. U.S. National Library of Medicine.
 | This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by . |
Categories:
- Drugs not assigned an ATC code
- Combination drugs
- Gastrointestinal system drug stubs